Medical | Australian Biotech News

Home Tags Medical

Ngaiire Media

Mallinckrodt Teams up with UK RNAi Biotech in Deal Worth up...

Ngaiire - July 19, 2019

Ngaiire Media

Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs

Ngaiire - July 18, 2019

Ngaiire Media

Scientists in Belgium Cure Anthrax in Mice by Smashing Bacteria’s Armor

Ngaiire - July 17, 2019

Ngaiire Media

French Startup’s Universal Flu Vaccine Development Boosted by €8M Series A

Ngaiire - July 10, 2019

Ngaiire Media

Evotec Spinoff to Develop Cancer Drugs that Block DNA Repair

Ngaiire - July 8, 2019

Ngaiire Media

French Biotech’s Plant Extract Cuts Blood Glucose in Prediabetic People

Ngaiire - July 5, 2019

Ngaiire Media

Dutch Antibodies for Autoimmune Diseases Boosted by €15M Series A

Ngaiire - July 4, 2019

Ngaiire Media

EU Approves Two-Drug Pill as First-Line Treatment for HIV

Ngaiire - July 3, 2019

Ngaiire Media

Microbiome Food Supplement Improves Metabolic Syndrome in Overweight People

Ngaiire - July 2, 2019

Ngaiire Media

Approval Status of Cancer Cell Therapy at Risk After Halting Phase...

Ngaiire - July 1, 2019

12 3 4 Page 1 of 4

Stay connected

Recent posts

George Mason University breast cancer treatment patent licensed by Targeted Pharmaceuticals

Ngaiire - July 23, 2019

Researchers unveil experimental compound to block therapeutic target in blood cancer

Ngaiire - July 22, 2019

Turning Shelved Drugs into a New Promise for Immuno-Oncology

Ngaiire - July 22, 2019

Random article

George Mason University breast cancer treatment patent licensed by Targeted Pharmaceuticals

Researchers unveil experimental compound to block therapeutic target in blood cancer

Turning Shelved Drugs into a New Promise for Immuno-Oncology

Martian Gravity